Showing 25 of 29 results
- pooled clone sequencing of DNA cloning sampleLab: Yin Shen, UCSFProject: ENCODE
- growth-based CRISPR interference screen of PC-3Homo sapiens PC-3 genetically modified using CRISPR, transduction 14 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- growth-based CRISPR interference screen of DU 145Homo sapiens DU 145 genetically modified using CRISPR, transduction 14 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- growth-based CRISPR interference screen of NCI-H460Homo sapiens NCI-H460 genetically modified using CRISPR, transduction 14 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- growth-based CRISPR interference screen of MDA-MB-231Homo sapiens MDA-MB-231 genetically modified using CRISPR, transduction 14 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- growth-based CRISPR interference screen of MCF-7Homo sapiens MCF-7 genetically modified using CRISPR, transduction 14 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- growth-based CRISPR interference screen of HepG2Homo sapiens HepG2 genetically modified using CRISPR, transduction 14 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- growth-based CRISPR interference screen of SW620Homo sapiens SW620 genetically modified using CRISPR, transduction 14 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- growth-based CRISPR interference screen of HCT116Homo sapiens HCT116 genetically modified using CRISPR, transduction 14 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- growth-based CRISPR interference screen of K562Homo sapiens K562 genetically modified using CRISPR, transduction 14 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- Control CRISPR screen of PC-3Homo sapiens PC-3 genetically modified using CRISPR, transduction 0 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- Control CRISPR screen of DU 145Homo sapiens DU 145 genetically modified using CRISPR, transduction 0 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- Control CRISPR screen of NCI-H460Homo sapiens NCI-H460 genetically modified using CRISPR, transduction 0 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- Control CRISPR screen of MDA-MB-231Homo sapiens MDA-MB-231 genetically modified using CRISPR, transduction 0 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- Control CRISPR screen of MCF-7Homo sapiens MCF-7 genetically modified using CRISPR, transduction 0 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- Control CRISPR screen of HepG2Homo sapiens HepG2 genetically modified using CRISPR, transduction 0 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- Control CRISPR screen of SW620Homo sapiens SW620 genetically modified using CRISPR, transduction 0 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- Control CRISPR screen of HCT116Homo sapiens HCT116 genetically modified using CRISPR, transduction 0 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- Control CRISPR screen of K562Homo sapiens K562 genetically modified using CRISPR, transduction 0 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- pooled clone sequencing of DNA cloning sampleLab: Bing Ren, UCSDProject: ENCODE
- pooled clone sequencing of DNA cloning sampleLab: Tim Reddy, DukeProject: GGR
- STARR-seq of MCF-7Homo sapiens MCF-7 genetically modified using transient transfectionLab: Kevin White, UChicagoProject: ENCODE
- STARR-seq of HCT116Homo sapiens HCT116 genetically modified using transient transfectionLab: Kevin White, UChicagoProject: ENCODE
- STARR-seq of SH-SY5YHomo sapiens SH-SY5Y genetically modified using transient transfectionLab: Kevin White, UChicagoProject: ENCODE
- STARR-seq of HepG2Homo sapiens HepG2 genetically modified using transient transfectionLab: Kevin White, UChicagoProject: ENCODE